An array of syngeneic cancer models in mice, including B16‐F10 melanoma, MC38 colon cancer, and CT26 colon cancer, were employed to evaluate the effectiveness of IFN‐α‐iPSC‐pMCs. The gene discussed is IFNA1; the disease is malignant colon neoplasm.